Helicobacter pylori L-form and patients with chronic gastritis

doi:10.3748/wjg.v10.i9.1306

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2675)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

381

HTML

2006

Tables (1-4)

288

Sum=2675

May 1, 2004 (publication date) through Mar 2, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

H Pylori

World J Gastroenterol. May 1, 2004; 10(9): 1306-1309
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1306

Table 1 Comparation of Gram staining and immunohis-tochemistry staining in detection of Helicobacter pylori L-forms

Gram staining (n)	Immunohistochemistry staining (n)		Total (n)
Gram staining (n)	Positive	Negative	Total (n)
Positive	209	17	226
Negative	7	195	202
Total	216	212	428

χ² = 0.46779, P > 0.05 between the 2 methods.

Table 2 Relationship of infection of Helicobacter pylori L-forms with gender and age of patients with chronic gastritis

Age(yr)	Male		Female		Total
Age(yr)	n	Detection rate (%)	n	Detection rate (%)	n	Detection rate (%)
14-	62	31 (50.00)	75	17 (22.67)	137	48 (35.04)^b
30-	37	14 (37.84)	48	18 (37.50)	85	32 (37.65)^b
40-	55	35 (63.64)	23	12 (52.17)	78	47 (60.26)^b
50-	81	56 (69.14)	47	26 (55.32)	128	82 (64.06)^b
Total	235	136 (57.87 )^d	193	73 (37.82)^d	428	209 (48.83)

^dχ² = 17.05, P < 0.01;

^bχ² = 33.74, P < 0.01.

Table 3 Detection of T lymphocyte subsets in patients with chronic gastritis in relation to infection with Helicobacter pylori and its L-forms

Group	n	CD3+ (%)	CD4+ (%)	CD8+ (%)	CD4+/CD8+
Hp (-)	202	60.72 ± 8.38^b	36.33 ± 3.68^d	25.83 ± 6.93	1.55 ± 0.34^j
Hp (+)	226	47.58 ± 4.44^b	25.51 ± 4.74^d	22.77 ± 7.46	1.44 ± 0.51^j
Hp-L (-)	17	50.81 ± 6.20	33.74 ± 5.34^f	25.04 ± 10.48	1.68 ± 0.58^h
Hp-L (+)	209	46.67 ± 5.21	30.75 ± 4.89^f	22.15 ± 6.45	1.32 ± 0.47^h
Total	428	52.20 ± 6.21	34.31 ± 4.18	23.49 ± 6.86	1.16 ± 0.466

^bP < 0.001, t = 20.61;

^dP < 0.001, t = 26.21;

^jP < 0.001, t = 4.36;

^fP < 0.001, t = 7.78;

^hP < 0.01, t = 2.99. Hp: Helicobacter pylori.

Table 4 Detection of serum IL-2, IL-6 and IL-8 in patients with chronic gastritis in relation to infection with Helicobacter pylori and its L-forms

Group	n	IL-2 (mg/L)	IL-6 (ng/L)	IL-8 (ng/L)
Hp (-)	202	6.14 ± 0.65^b	36.82 ± 3.15^d	48.35 ± 3.63^f
Hp (+)	226	1.56 ± 0.47^b	103.62 ± 5.85^d	109.79 ± 7.18^f
Hp-L (-)	17	3.39 ± 0.57^h	63.35 ± 6.51^j	82.33 ± 8.45^l
Hp-L (+)	209	1.16 ± 0.38^h	116.45 ± 5.44^j	118.64 ± 6.24^l
Total	428	3.27 ± 0.52	81.83 ± 4.73	87.53 ± 5.68

^bP < 0.001, t = 83.06;

^dP < 0.001, t = 145.3;

^fP < 0.001, t = 110.3;

^hP < 0.001, t = 21.08;

^jP < 0.001, t = 38.45;

^lP < 0.001, t = 22.61. Hp: Helicobacter pylori.

Citation: Wang KX, Chen L. Helicobacter pylori L-form and patients with chronic gastritis. World J Gastroenterol 2004; 10(9): 1306-1309
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1306.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1306